Mutation of <i>PA4292</i> in Pseudomonas aeruginosa Increases β-Lactam Resistance through Upregulating Pyocyanin Production

Xinrui Zhao, Yongxin Jin, Fang Bai, Zhihui Cheng, Weihui Wu, Xiaolei Pan

Antimicrobial Agents and Chemotherapy · 2022 · 11 citations · 28 references

DOIFull text

Open access

Concepts

Abstract

Metallo-β-lactamase (MBL)-producing Pseudomonas aeruginosa is increasingly reported worldwide and usually causes infections with high mortality rates. Aztreonam/avibactam is a β-lactam/β-lactamase inhibitor (BLBLI) combination that is under clinical trials.

References

28